{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:12:54Z","timestamp":1790248374067,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Lesotho has among the world\u2019s highest TB prevalences and the national program finding only 50% of incident cases. Lesotho underwent its first TB prevalence study in 2019 in reviewing this study, the authors recognized that the standard measures for screening and diagnosis TB often failed to detect the presence of culture positive pulmonary TB. This review seeks to determine if the systematic under detection of culture positive TB by standard methods is true among prevalence surveys in Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a review to identify TB prevalence surveys conducted in Africa from 2011 to 2024. Seventeen surveys meeting inclusion criteria were identified. For each survey, we extracted the proportion of culture-confirmed TB cases that were also identified by symptom screening, chest X-ray (CXR), sputum smear microscopy, and GeneXpert MTB\/RIF. We additionally tabulated national HIV prevalence, HIV co-infection rates reported by national TB programs, and HIV co-infection rates documented in the prevalence surveys themselves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TB prevalence across the 17 surveyed countries ranged from 119 per 100,000 population in Rwanda to 737 per 100,000 in South Africa, with Lesotho (581), Tanzania (590), Zambia (638), Kenya (558), Nigeria (524), Uganda (401), Namibia (465), Malawi (452), Ghana (356), Eswatini (352), Mozambique (334), Zimbabwe (344), Gambia (212), Sudan (183), and Ethiopia (183) recording intermediate burdens. Symptom screening missed an average of 50% of culture-confirmed pulmonary TB cases across all surveys. Smear microscopy missed approximately 60% of bacteriologically confirmed cases. GeneXpert, while more sensitive, still missed an average of 30\u201335% of culture-confirmed cases even under rigorous study conditions. In contrast, CXR demonstrated concordance exceeding 80% with culture-confirmed TB across almost all surveyed countries. HIV co-infection among TB patients in prevalence surveys was consistently lower than rates reported in national TB programs, suggesting systematic underrepresentation of HIV-positive individuals in survey populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Symptoms-based screening and GeneXpert alone are insufficient to detect the majority of people with active, bacteriologically confirmed TB. Chest X-ray, with markedly higher sensitivity than symptom screening or molecular testing under real-world survey conditions, should be repositioned as a primary screening tool in high-burden settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1941743","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:51:17Z","timestamp":1790247077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of tuberculosis prevalence surveys in Africa: evidence to change the status quo in case finding"],"prefix":"10.3389","volume":"14","author":[{"given":"Joia S.","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Department of Medicine, Massachusetts General Brigham","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melino","family":"Ndayizigye","sequence":"additional","affiliation":[{"name":"Partners In Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa","family":"Lee","sequence":"additional","affiliation":[{"name":"Chelsea and Westminster Hospital NHS Foundation Trust","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gilmore","sequence":"additional","affiliation":[{"name":"Northeastern Bouve College of Health Sciences","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirine","family":"Benali","sequence":"additional","affiliation":[{"name":"Ariadne Laboratory","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llang","family":"Maama","sequence":"additional","affiliation":[{"name":"Government of Lesotho","place":["Maseru, Lesotho"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afom T.","family":"Andom","sequence":"additional","affiliation":[{"name":"Partners In Health","place":["Maseru, Lesotho"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref1","volume-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.1093\/clinids\/11.Supplement_2.S339","article-title":"Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries","volume":"11","author":"Styblo","year":"1989","journal-title":"Rev Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.5588\/ijtld.17.0893","article-title":"Burden, spectrum and outcomes of children with tuberculosis diagnosed at a district-level hospital in South Africa","volume":"22","author":"du Preez","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.4102\/phcfm.v12i1.2012","article-title":"The execution rate of procedures to diagnose extrapulmonary tuberculosis in Botswana","volume":"12","author":"Mudiayi","year":"2020","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0035-9203(95)90668-1","article-title":"The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia","volume":"89","author":"Elliott","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e1721","DOI":"10.1371\/journal.pone.0001721","article-title":"Has the DOTS strategy improved case finding or treatment success? An empirical assessment","volume":"3","author":"Obermeyer","year":"2008","journal-title":"PLoS One"},{"key":"ref7","first-page":"52","article-title":"Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima ciudad, Peru","volume":"8","author":"Chavez Pachas","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/JCM.01463-09","article-title":"Rapid detection of mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology","volume":"48","author":"Helb","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12879-018-3387-z","article-title":"Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010\u20132015","volume":"18","author":"Surie","year":"2010","journal-title":"BMC Infect Dis"},{"key":"ref11","volume-title":"Tuberculosis Prevalence Surveys: a Handbook","year":"2011"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-7622-10-10","article-title":"Analysis of tuberculosis prevalence surveys: new guidance on best-practice methods","volume":"10","author":"Floyd","year":"2013","journal-title":"Emerg Themes Epidemiol"},{"key":"ref13","year":""},{"key":"ref14","volume-title":"Namibia TB Prevalence Survey Report 2019","year":"2020"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0273245","DOI":"10.1371\/journal.pone.0273245","article-title":"Policy and programmatic directions for the Lesotho tuberculosis programme: findings of the national tuberculosis prevalence survey, 2019","volume":"18","author":"Matji","year":"2023","journal-title":"PLoS One"},{"key":"ref16","volume-title":"TB Prevalence Survey Report 2018\u20132019","year":"2021"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/tmi.13485","article-title":"National tuberculosis prevalence surveys in Africa, 2008\u20132016: an overview of results and lessons learned","volume":"25","author":"Law","year":"2008","journal-title":"Trop Med Int Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/tmi.12534","article-title":"National tuberculosis prevalence surveys in Asia, 1990\u20132012: an overview of results and lessons learned","volume":"20","author":"Onozaki","year":"2015","journal-title":"Trop Med Int Health"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5588\/ijtld.21.0341","article-title":"TB prevalence in Zimbabwe: a national cross-sectional survey, 2014","volume":"26","author":"Chipinduro","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref20","unstructured":"Ghana national TB prevalence survey 2013\n          \n          \n          GHS\n          \n          2014"},{"key":"ref21","volume-title":"National TB Prevalence Survey Report 2012","year":"2013"},{"key":"ref22","unstructured":"The first National Tuberculosis Prevalence Survey Final Report\n          \n          \n          NTLP\n          \n          2013"},{"key":"ref23","volume-title":"National TB Prevalence Survey 2013\u20132014","year":"2016"},{"key":"ref24","article-title":"TB prevalence survey Ethiopia 2010\u20132011 preliminary results Ethiopian Ministry of Health","author":"Alebachew","year":"2012"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e0231372","DOI":"10.1371\/journal.pone.0231372","article-title":"Prevalence of tuberculosis in Rwanda: results of the first nationwide survey in 2012","volume":"15","author":"Migambi","year":"2020","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2471\/BLT.14.151670","article-title":"A tuberculosis nationwide prevalence survey in Gambia, 2012","volume":"94","author":"Adetifa","year":"2016","journal-title":"Bull World Health Organ"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e0209098","DOI":"10.1371\/journal.pone.0209098","article-title":"Kenya tuberculosis prevalence survey 2016: challenges and opportunities of ending TB in Kenya","volume":"13","author":"Enos","year":"2018","journal-title":"PLoS One"},{"key":"ref28","volume-title":"Uganda National Tuberculosis Prevalence Survey 2014\u20132015","year":"2016"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41467-023-37314-1","article-title":"Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics","volume":"14","author":"Dodd","year":"2023","journal-title":"Nat Commun"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/tmi.12536","article-title":"The first national tuberculosis prevalence survey of Lao PDR (2010-2011)","volume":"20","author":"Law","year":"2015","journal-title":"Trop Med Int Health"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e0000588","DOI":"10.1371\/journal.pgph.0000588","article-title":"The fourth national tuberculosis prevalence survey in Myanmar","volume":"2","author":"Aung","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"100278","DOI":"10.1016\/j.jctube.2021.100278","article-title":"Gaps related to screening and diagnosis of tuberculosis in care cascade in selected health facilities in East Africa: a retrospective study","volume":"25","author":"Mnyambwa","year":"2021","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"10.1186\/s12879-017-2388-7","DOI":"10.1186\/s12879-017-2388-7","article-title":"Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts","volume":"17","author":"Muyoyeta","year":"2017","journal-title":"BMC Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1016\/S2589-7500(21)00142-4","article-title":"Can AI technologies close the diagnostic gap in tuberculosis?","volume":"3","author":"Tzelios","year":"2021","journal-title":"Lancet Digit Health"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13104-017-2420-4","article-title":"Digital chest X-ray through a mobile van: public private partnership to detect sputum negative pulmonary TB","volume":"10","author":"Datta","year":"2017","journal-title":"BMC Res Notes"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12941-020-00363-1","article-title":"Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes","volume":"19","author":"Togun","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/tropicalmed8030165","article-title":"The impact of COVID-19 on tuberculosis program performance in the Kingdom of Lesotho","volume":"8","author":"Andom","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e2400024","DOI":"10.9745\/GHSP-D-24-00024","article-title":"An effective health system approach to end TB: implementing the double X strategy in Vietnam","volume":"12","author":"Innes","year":"2024","journal-title":"Glob Health Sci Pract"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMoa1902129","article-title":"Community-wide screening for tuberculosis in a high-prevalence setting","volume":"381","author":"Marks","year":"2019","journal-title":"N Engl J Med"},{"key":"ref40","year":""},{"key":"ref41","year":""},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e70008","DOI":"10.1002\/jia2.70008","article-title":"HIV incidence and prevalence among adults in Mozambique: estimates from the Population-based HIV Impact Assessment Survey (INSIDA 2021) and district-level modelling","volume":"28","author":"Gudo","year":"2025","journal-title":"J Int AIDS Soc."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4236\/jtr.2018.62013","article-title":"First nationwide survey of the prevalence of TB\/HIV co-infection in Ghana","volume":"6","author":"Addo","year":"2018","journal-title":"J Tuberc Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.33073\/pjm-2021-017","article-title":"Screening of HIV among newly diagnosed tuberculosis patients in eastern Sudan","volume":"70","author":"Mustafa","year":"2021","journal-title":"Pol J Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.24875\/AIDSRev.20000068","article-title":"Coinfection of tuberculosis and HIV in Nigeria: a systematic review and Meta-analysis","volume":"23","author":"Reward","year":"2025","journal-title":"AIDS Rev"},{"key":"ref46","year":""}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1941743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:51:21Z","timestamp":1790247081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1941743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":46,"alternative-id":["10.3389\/fpubh.2026.1941743"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1941743","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1941743"}}